Pelizaeus Merzbacher disease (PMD) is a dysmyelinating disorder of the central nervous system caused by impaired differentiation of oligodendrocytes. This study was prompted by findings that ...
New insight into the underlying mechanisms of a rare and fatal pediatric dymyelinating disease suggests older medications approved by the US Food and Drug Administration (FDA) may help these patients.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback